tiprankstipranks
Lexicon reports Q3 EPS (18c), consensus (16c)
PremiumThe FlyLexicon reports Q3 EPS (18c), consensus (16c)
10d ago
Lexicon Pharmaceuticals options imply 14.8% move in share price post-earnings
Premium
The Fly
Lexicon Pharmaceuticals options imply 14.8% move in share price post-earnings
10d ago
Lexicon announces JASN publishes sotagliflozin data
Premium
The Fly
Lexicon announces JASN publishes sotagliflozin data
17d ago
FDA Endocrinologic and Metabolic Drugs Advisory Committee to hold a meeting
PremiumThe FlyFDA Endocrinologic and Metabolic Drugs Advisory Committee to hold a meeting
27d ago
Lexicon announces new analysis of Phase 3 SCORED trial
Premium
The Fly
Lexicon announces new analysis of Phase 3 SCORED trial
1M ago
Lexicon’s LX9211 progressing ahead of schedule, says H.C. Wainwright
Premium
The Fly
Lexicon’s LX9211 progressing ahead of schedule, says H.C. Wainwright
1M ago
Lexicon announces departure of President, COO Jeff Wade
PremiumThe FlyLexicon announces departure of President, COO Jeff Wade
2M ago
Lexicon Pharmaceuticals Announces Executive Leadership Changes
Premium
Company Announcements
Lexicon Pharmaceuticals Announces Executive Leadership Changes
2M ago
Lexicon management to meet with Piper Sandler
Premium
The Fly
Lexicon management to meet with Piper Sandler
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100